Greenwich Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.61M Buy
2,840
+30
+1% +$30.4K 0.11% 102
2025
Q4
$3.02M Sell
2,810
-70
-2% -$66.9K 0.13% 89
2025
Q3
$2.2M Buy
2,880
+107
+4% +$79.6K 0.11% 98
2025
Q2
$2.16M Sell
2,773
-4
-0.1% -$3.11K 0.1% 86
2025
Q1
$2.29M Sell
2,777
-134
-5% -$112K 0.17% 69
2024
Q4
$2.25M Buy
2,911
+64
+2% +$53K 0.16% 74
2024
Q3
$2.52M Buy
2,847
+439
+18% +$395K 0.17% 70
2024
Q2
$2.18M Sell
2,408
-70
-3% -$56K 0.16% 72
2024
Q1
$1.93M Buy
2,478
+628
+34% +$447K 0.15% 74
2023
Q4
$1.08M Buy
1,850
+13
+0.7% +$7.59K 0.11% 99
2023
Q3
$987K Sell
1,837
-82
-4% -$42.3K 0.1% 101
2023
Q2
$900K Buy
1,919
+55
+3% +$23.1K 0.09% 111
2023
Q1
$640K Sell
1,864
-197
-10% -$66.4K 0.07% 143
2022
Q4
$754K Sell
2,061
-13
-0.6% -$4.61K 0.08% 124
2022
Q3
$670K Sell
2,074
-195
-9% -$61.8K 0.07% 132
2022
Q2
$736K Buy
2,269
+88
+4% +$26.4K 0.1% 130
2022
Q1
$625K Sell
2,181
-112
-5% -$28.8K 0.06% 142
2021
Q4
$633K Sell
2,293
-101
-4% -$25.6K 0.05% 146
2021
Q3
$553K Buy
2,394
+41
+2% +$10.1K 0.05% 148
2021
Q2
$540K Buy
2,353
+535
+29% +$107K 0.05% 140
2021
Q1
$340K Sell
1,818
-321
-15% -$62.8K 0.03% 161
2020
Q4
$361K Buy
2,139
+271
+15% +$40.5K 0.03% 142
2020
Q3
$277K Buy
1,868
+22
+1% +$3.4K 0.05% 154
2020
Q2
$303K Buy
1,846
+137
+8% +$21K 0.06% 141
2020
Q1
$237K Buy
+1,709
New +$235K 0.05% 150

Other funds holding LLY

Greenwich Wealth Management's LLY Position: Q1 2026 in Review

Greenwich Wealth Management increased its Eli Lilly (LLY) stake by 1.1% in Q1 2026, buying an estimated $30.4K and bringing the position to 2,840 shares worth $2.61M. The position accounts for 0.11% of the portfolio, ranked #102.

Greenwich Wealth Management first reported a position in LLY in Q1 2020 and has held it in 25 quarters since. The position peaked at $3.02M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Greenwich Wealth Management held 2,840 shares of Eli Lilly worth $2.61M as of Q1 2026.
  • Greenwich Wealth Management bought 30 Eli Lilly shares in Q1 2026, an estimated $30.4K.
  • Eli Lilly made up 0.11% of Greenwich Wealth Management's portfolio in Q1 2026, its #102 holding.
  • Greenwich Wealth Management first reported a position in Eli Lilly in Q1 2020 and has held it in 25 quarters since.
  • Greenwich Wealth Management's Eli Lilly position peaked at $3.02M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Greenwich Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.